The proteasome: a novel target for cancer chemotherapy
Top Cited Papers
- 1 April 2002
- journal article
- review article
- Published by Springer Nature in Leukemia
- Vol. 16 (4) , 433-443
- https://doi.org/10.1038/sj.leu.2402417
Abstract
Leukemia is one of the leading journals in hematology and oncology. It is published monthly and covers all aspects of the research and treatment of leukemia and allied diseases. Studies of normal hemopoiesis are covered because of their comparative relevance.Keywords
This publication has 74 references indexed in Scilit:
- Proteasome inhibitor-induced apoptosis of B-chronic lymphocytic leukaemia cells involves cytochrome c release and caspase activation, accompanied by formation of an ∼700 kDa Apaf-1 containing apoptosome complexLeukemia, 2001
- Ubiquitin-Proteasome System and Increased Sensitivity of B-CLL Lymphocytes to Apoptotic Death ActivationLeukemia & Lymphoma, 2000
- Diverse functions of JNK signaling and c-Jun in stress response and apoptosisOncogene, 1999
- Increased sensitivity of CLL‐derived lymphocytes to apoptotic death activation by the proteasome‐specific inhibitor lactacystinBritish Journal of Haematology, 1999
- The role of the ubiquitin-proteasome pathway in apoptosisCell Death & Differentiation, 1999
- The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappa B that blocks TNFalpha -induced apoptosisGenes & Development, 1999
- Inhibition of Proteasome Function Prevents Thymocyte Apoptosis: Involvement of Ornithine DecarboxylaseBiochemical and Biophysical Research Communications, 1998
- The Proteasome Is Involved in AngiogenesisBiochemical and Biophysical Research Communications, 1998
- Lactacystin, a Specific Inhibitor of the Proteasome, Induces Apoptosis in Human Monoblast U937 CellsBiochemical and Biophysical Research Communications, 1995
- p53 Mutations in Human CancersScience, 1991